179 related articles for article (PubMed ID: 10091481)
1. Genital angiofibromas in tuberous sclerosis: two cases.
Nico MM; Ito LM; Valente NY
J Dermatol; 1999 Feb; 26(2):111-4. PubMed ID: 10091481
[TBL] [Abstract][Full Text] [Related]
2. Unilateral facial angiofibromas--a segmental form of tuberous sclerosis.
McGrae JD; Hashimoto K
Br J Dermatol; 1996 Apr; 134(4):727-30. PubMed ID: 8733380
[TBL] [Abstract][Full Text] [Related]
3. Unilateral facial angiofibromas; a review of the literature.
Camprubí M; Balaguer A; Azon Masoliver A; Jiménez-Feijoo R; Escribano Subias J
Pediatr Dermatol; 2006; 23(3):303-5. PubMed ID: 16780491
[No Abstract] [Full Text] [Related]
4. Tuberous Sclerosis with Severe Cutaneous Manifestation and Multiples Facial Angiofibromas.
Garcia NG; de Carli ML; Oliveira DT; Soares CT; Ribeiro Júnior NV; Sperandio FF; Hanemann JA
Head Neck Pathol; 2016 Dec; 10(4):542-546. PubMed ID: 27140177
[TBL] [Abstract][Full Text] [Related]
5. New technique using combined pulsed dye laser and fractional resurfacing for treating facial angiofibromas in tuberous sclerosis.
Weiss ET; Geronemus RG
Lasers Surg Med; 2010 Jul; 42(5):357-60. PubMed ID: 20583249
[TBL] [Abstract][Full Text] [Related]
6. Unilateral facial angiofibromas without other evidence of tuberous sclerosis: case report and review of the literature.
Hall MR; Kovach BT; Miller JL
Cutis; 2007 Oct; 80(4):284-8. PubMed ID: 18038689
[TBL] [Abstract][Full Text] [Related]
7. Comparative Effects of Topical 0.2% Sirolimus for Angiofibromas in Adults and Pediatric Patients with Tuberous Sclerosis Complex.
Lee YI; Lee JH; Kim DY; Chung KY; Shin JU
Dermatology; 2018; 234(1-2):13-22. PubMed ID: 29925060
[TBL] [Abstract][Full Text] [Related]
8. Unilateral multiple facial angiofibromas: a mosaic form of tuberous sclerosis.
Silvestre JF; Bañuls J; Ramón R; Guijarro J; Botella R; Betlloch I
J Am Acad Dermatol; 2000 Jul; 43(1 Pt 1):127-9. PubMed ID: 10863238
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and Safety of Topical Rapamycin in Patients With Facial Angiofibromas Secondary to Tuberous Sclerosis Complex: The TREATMENT Randomized Clinical Trial.
Koenig MK; Bell CS; Hebert AA; Roberson J; Samuels JA; Slopis JM; Tate P; Northrup H;
JAMA Dermatol; 2018 Jul; 154(7):773-780. PubMed ID: 29800048
[TBL] [Abstract][Full Text] [Related]
10. The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis.
Hofbauer GF; Marcollo-Pini A; Corsenca A; Kistler AD; French LE; Wüthrich RP; Serra AL
Br J Dermatol; 2008 Aug; 159(2):473-5. PubMed ID: 18547304
[TBL] [Abstract][Full Text] [Related]
11. Sun exposure causes somatic second-hit mutations and angiofibroma development in tuberous sclerosis complex.
Tyburczy ME; Wang JA; Li S; Thangapazham R; Chekaluk Y; Moss J; Kwiatkowski DJ; Darling TN
Hum Mol Genet; 2014 Apr; 23(8):2023-9. PubMed ID: 24271014
[TBL] [Abstract][Full Text] [Related]
12. Treatment of the facial angiofibromas of tuberous sclerosis.
Verheyden CN
Plast Reconstr Surg; 1996 Oct; 98(5):777-83. PubMed ID: 8823013
[TBL] [Abstract][Full Text] [Related]
13. [Multiple and unilateral angiofibromas of the face: forme fruste of Bourneville tuberous sclerosis].
García Muret MP; Pujol RM; de Moragas JM
Ann Dermatol Venereol; 1998 May; 125(5):325-7. PubMed ID: 9747280
[TBL] [Abstract][Full Text] [Related]
14. [Facial angiofibromas associated to tuberous sclerosis treated with topical sirolimus].
Tiedemann Svendsen M; Bygum A; Hansen LK; Broesby-Olsen S
Ugeskr Laeger; 2013 Oct; 175(43):2569-70. PubMed ID: 24629155
[TBL] [Abstract][Full Text] [Related]
15. Oral manifestations leading to the diagnosis of familial tuberous sclerosis.
Martelli H; Lima LS; Bonan PR; Coletta RD
Indian J Dent Res; 2010; 21(1):138-40. PubMed ID: 20427926
[TBL] [Abstract][Full Text] [Related]
16. Sirolimus Gel Treatment vs Placebo for Facial Angiofibromas in Patients With Tuberous Sclerosis Complex: A Randomized Clinical Trial.
Wataya-Kaneda M; Ohno Y; Fujita Y; Yokozeki H; Niizeki H; Ogai M; Fukai K; Nagai H; Yoshida Y; Hamada I; Hio T; Shimizu K; Murota H
JAMA Dermatol; 2018 Jul; 154(7):781-788. PubMed ID: 29800026
[TBL] [Abstract][Full Text] [Related]
17. A novel topical rapamycin cream for the treatment of facial angiofibromas in tuberous sclerosis complex.
Wheless JW; Almoazen H
J Child Neurol; 2013 Jul; 28(7):933-6. PubMed ID: 23680945
[TBL] [Abstract][Full Text] [Related]
18. Tuberous sclerosis with oral angiofibroma: case report.
Prabhu S; Mahesh KP
Br J Oral Maxillofac Surg; 2010 Apr; 48(3):205-7. PubMed ID: 19640621
[TBL] [Abstract][Full Text] [Related]
19. Multiple facial angiofibromas and collagenomas in patients with multiple endocrine neoplasia type 1.
Darling TN; Skarulis MC; Steinberg SM; Marx SJ; Spiegel AM; Turner M
Arch Dermatol; 1997 Jul; 133(7):853-7. PubMed ID: 9236523
[TBL] [Abstract][Full Text] [Related]
20. Analysis of current data on the use of topical rapamycin in the treatment of facial angiofibromas in tuberous sclerosis complex.
Balestri R; Neri I; Patrizi A; Angileri L; Ricci L; Magnano M
J Eur Acad Dermatol Venereol; 2015 Jan; 29(1):14-20. PubMed ID: 25174683
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
